Effects of a Saccharomyces cerevisiae fermentation product in receiving diets of newly weaned beef steers. I. Growth performance and antioxidant defense1
| Autor: | Erin L Deters, Rebecca S. Stokes, Olivia N Genther-Schroeder, Stephanie L. Hansen |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Male Antioxidant medicine.medical_treatment Randomized block design Saccharomyces cerevisiae Weaning Beef cattle Antioxidants 03 medical and health sciences chemistry.chemical_compound Animal science Genetics medicine Animals Chemistry Diarrhea Virus 1 Bovine Viral Body Weight 0402 animal and dairy science Antibody titer 04 agricultural and veterinary sciences General Medicine Glutathione Malondialdehyde 040201 dairy & animal science Animal Feed Diet Red Meat 030104 developmental biology Feedlot Dietary Supplements Fermentation Animal Science and Zoology Cattle Lysozyme Ruminant Nutrition Food Science |
| Zdroj: | Journal of animal science. 96(9) |
| ISSN: | 1525-3163 |
| Popis: | To evaluate the effects of a Saccharomyces cerevisiae fermentation product (SCFP; Original XPC, Diamond V, Cedar Rapids, IA) on growth performance and antioxidant defense of newly weaned beef cattle, 180 single-source steers (278 ± 21 kg; SD) were used in a 56-d receiving study. Seven days after arrival, steers were blocked by body weight (BW) to pens of 6 and randomly assigned to treatments: SCFP at 0 (CON), 14 (SCFP14), or 28 (SCFP28) g·steer(−1)·d(−1). Pen was the experimental unit (n = 10 per treatment). On day 0, steers were boostered against Bovine Viral Diarrhea Virus (BVDV) Type 1 and 2 (Vista Once, Merck, Madison, NJ). Weights were collected on days 1, 0, 14, 27, 42, 55, and 56. One steer per pen was bled on days 0, 14, 27, 42, and 56 for analysis of BVDV antibody titers; blood from days 0, 27, and 56 was analyzed for red blood cell lysate superoxide dismutase (SOD) activity and glutathione (total = tGSH, oxidized = GSSG, and reduced = GSH) concentrations, plasma malondialdehyde (MDA) concentrations, and serum lysozyme activity. Performance and blood data were analyzed as a randomized complete block design using Proc Mixed of SAS with fixed effects of treatment and block and random effect of pen. Linear and quadratic contrast statements were used. Antibody titers were log transformed and analyzed as repeated measures. There were no treatment by day interactions (P ≥ 0.16), and no linear or quadratic effects of SCFP on feedlot performance, antibody titers, or lysozyme activity (P > 0.10). Day 27 MDA concentrations tended to linearly increase (P = 0.09). A quadratic effect of SCFP on day 56 SOD activity (P = 0.004) was driven by lesser activity for SCFP14-fed steers. On day 27, a tendency for a quadratic effect of SCFP (P = 0.09) on GSH was driven by greater concentrations for SCFP14-fed steers resulting in a lesser GSSG:GSH ratio (P = 0.05). Greater GSH for SCFP14-fed steers caused a tendency for a quadratic effect on day 56 (P = 0.07); however, this did not result in an effect of SCFP on the GSSG:GSH ratio (P ≥ 0.25). A tendency for a linear effect of SCFP on tGSH was noted on day 56 (P = 0.09). Morbidity data were analyzed using Proc Glimmix of SAS. There was a quadratic effect of SCFP on percentage of respiratory treatments prior to day 14 (P = 0.04). These results could indicate lesser levels of oxidative stress for steers receiving SCFP at 14 vs. 0 or 28 g/d. Under the conditions of this study, no performance benefit of SCFP was noted. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|